CYBB and chronic granulomatous disease: Braut et al. demonstrated the therapeutic potential of NOX2/p22phox liposomes to transport and deliver recombinant cytochrome b558 to the membrane of X0-linked CGD (X0-CGD) iPSC-derived macrophages and restore the NOX2 activity [54].